Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin
Importance: Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment.
Objective: To determine whether dispatch of MSUs is associated with better clinical outcomes for patients with acute ischemic stroke.
Design, Setting, and Participants: This prospective, nonrandomized, controlled intervention study was conducted in Berlin, Germany, from February 1, 2017, to October 30, 2019. If an emergency call prompted suspicion of stroke, both a conventional ambulance and an MSU, when available, were dispatched. Functional outcomes of patients with final diagnosis of acute cerebral ischemia who were eligible for thrombolysis or thrombectomy were compared based on the initial dispatch (both MSU and conventional ambulance or conventional ambulance only).
Exposure: Simultaneous dispatch of an MSU (computed tomographic scanning with or without angiography, point-of-care laboratory testing, and thrombolysis capabilities on board) and a conventional ambulance (n = 749) vs conventional ambulance alone (n = 794).
Main Outcomes and Measures: The primary outcome was the distribution of modified Rankin Scale (mRS) scores (a disability score ranging from 0, no neurological deficits, to 6, death) at 3 months. The coprimary outcome was a 3-tier disability scale at 3 months (none to moderate disability; severe disability; death) with tier assignment based on mRS scores if available or place of residence if mRS scores were not available. Common odds ratios (ORs) were used to quantify the association between exposure and outcome; values less than 1.00 indicated a favorable shift in the mRS distribution and lower odds of higher levels of disability.
Results: Of the 1543 patients (mean age, 74 years; 723 women [47%]) included in the adjusted primary analysis, 1337 (87%) had available mRS scores (primary outcome) and 1506 patients (98%) had available the 3-tier disability scale assessment (coprimary outcome). Patients with an MSU dispatched had lower median mRS scores at month 3 (1; interquartile range [IQR], 0-3) than did patients without an MSU dispatched (2; IQR, 0-3; common OR for worse mRS, 0.71; 95% CI, 0.58-0.86; P < .001). Similarly, patients with an MSU dispatched had lower 3-month coprimary disability scores: 586 patients (80.3%) had none to moderate disability; 92 (12.6%) had severe disability; and 52 (7.1%) had died vs patients without an MSU dispatched: 605 (78.0%) had none to moderate disability; 103 (13.3%) had severe disability; and 68 (8.8%) had died (common OR for worse functional outcome, 0.73, 95% CI, 0.54-0.99; P = .04).
Conclusions and Relevance: In this prospective, nonrandomized, controlled intervention study of patients with acute ischemic stroke in Berlin, Germany, the dispatch of mobile stroke units, compared with conventional ambulances alone, was significantly associated with lower global disability at 3 months. Clinical trials in other regions are warranted.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:325 |
|---|---|
| Enthalten in: |
JAMA - 325(2021), 5 vom: 02. Feb., Seite 454-466 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Controlled Clinical Trial |
|---|
| Anmerkungen: |
Date Completed 15.02.2021 Date Revised 03.08.2021 published: Print CommentIn: JAMA. 2021 Feb 2;325(5):441-442. - PMID 33528517 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jama.2020.26345 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320894975 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320894975 | ||
| 003 | DE-627 | ||
| 005 | 20231225174644.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2020.26345 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1069.xml |
| 035 | |a (DE-627)NLM320894975 | ||
| 035 | |a (NLM)33528537 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ebinger, Martin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.02.2021 | ||
| 500 | |a Date Revised 03.08.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: JAMA. 2021 Feb 2;325(5):441-442. - PMID 33528517 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Importance: Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment | ||
| 520 | |a Objective: To determine whether dispatch of MSUs is associated with better clinical outcomes for patients with acute ischemic stroke | ||
| 520 | |a Design, Setting, and Participants: This prospective, nonrandomized, controlled intervention study was conducted in Berlin, Germany, from February 1, 2017, to October 30, 2019. If an emergency call prompted suspicion of stroke, both a conventional ambulance and an MSU, when available, were dispatched. Functional outcomes of patients with final diagnosis of acute cerebral ischemia who were eligible for thrombolysis or thrombectomy were compared based on the initial dispatch (both MSU and conventional ambulance or conventional ambulance only) | ||
| 520 | |a Exposure: Simultaneous dispatch of an MSU (computed tomographic scanning with or without angiography, point-of-care laboratory testing, and thrombolysis capabilities on board) and a conventional ambulance (n = 749) vs conventional ambulance alone (n = 794) | ||
| 520 | |a Main Outcomes and Measures: The primary outcome was the distribution of modified Rankin Scale (mRS) scores (a disability score ranging from 0, no neurological deficits, to 6, death) at 3 months. The coprimary outcome was a 3-tier disability scale at 3 months (none to moderate disability; severe disability; death) with tier assignment based on mRS scores if available or place of residence if mRS scores were not available. Common odds ratios (ORs) were used to quantify the association between exposure and outcome; values less than 1.00 indicated a favorable shift in the mRS distribution and lower odds of higher levels of disability | ||
| 520 | |a Results: Of the 1543 patients (mean age, 74 years; 723 women [47%]) included in the adjusted primary analysis, 1337 (87%) had available mRS scores (primary outcome) and 1506 patients (98%) had available the 3-tier disability scale assessment (coprimary outcome). Patients with an MSU dispatched had lower median mRS scores at month 3 (1; interquartile range [IQR], 0-3) than did patients without an MSU dispatched (2; IQR, 0-3; common OR for worse mRS, 0.71; 95% CI, 0.58-0.86; P < .001). Similarly, patients with an MSU dispatched had lower 3-month coprimary disability scores: 586 patients (80.3%) had none to moderate disability; 92 (12.6%) had severe disability; and 52 (7.1%) had died vs patients without an MSU dispatched: 605 (78.0%) had none to moderate disability; 103 (13.3%) had severe disability; and 68 (8.8%) had died (common OR for worse functional outcome, 0.73, 95% CI, 0.54-0.99; P = .04) | ||
| 520 | |a Conclusions and Relevance: In this prospective, nonrandomized, controlled intervention study of patients with acute ischemic stroke in Berlin, Germany, the dispatch of mobile stroke units, compared with conventional ambulances alone, was significantly associated with lower global disability at 3 months. Clinical trials in other regions are warranted | ||
| 650 | 4 | |a Controlled Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 650 | 7 | |a Tissue Plasminogen Activator |2 NLM | |
| 650 | 7 | |a EC 3.4.21.68 |2 NLM | |
| 700 | 1 | |a Siegerink, Bob |e verfasserin |4 aut | |
| 700 | 1 | |a Kunz, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Wendt, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Weber, Joachim E |e verfasserin |4 aut | |
| 700 | 1 | |a Schwabauer, Eugen |e verfasserin |4 aut | |
| 700 | 1 | |a Geisler, Frederik |e verfasserin |4 aut | |
| 700 | 1 | |a Freitag, Erik |e verfasserin |4 aut | |
| 700 | 1 | |a Lange, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Behrens, Janina |e verfasserin |4 aut | |
| 700 | 1 | |a Erdur, Hebun |e verfasserin |4 aut | |
| 700 | 1 | |a Ganeshan, Ramanan |e verfasserin |4 aut | |
| 700 | 1 | |a Liman, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Scheitz, Jan F |e verfasserin |4 aut | |
| 700 | 1 | |a Schlemm, Ludwig |e verfasserin |4 aut | |
| 700 | 1 | |a Harmel, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Zieschang, Katja |e verfasserin |4 aut | |
| 700 | 1 | |a Lorenz-Meyer, Irina |e verfasserin |4 aut | |
| 700 | 1 | |a Napierkowski, Ira |e verfasserin |4 aut | |
| 700 | 1 | |a Waldschmidt, Carolin |e verfasserin |4 aut | |
| 700 | 1 | |a Nolte, Christian H |e verfasserin |4 aut | |
| 700 | 1 | |a Grittner, Ulrike |e verfasserin |4 aut | |
| 700 | 1 | |a Wiener, Edzard |e verfasserin |4 aut | |
| 700 | 1 | |a Bohner, Georg |e verfasserin |4 aut | |
| 700 | 1 | |a Nabavi, Darius G |e verfasserin |4 aut | |
| 700 | 1 | |a Schmehl, Ingo |e verfasserin |4 aut | |
| 700 | 1 | |a Ekkernkamp, Axel |e verfasserin |4 aut | |
| 700 | 1 | |a Jungehulsing, Gerhard J |e verfasserin |4 aut | |
| 700 | 1 | |a Mackert, Bruno-Marcel |e verfasserin |4 aut | |
| 700 | 1 | |a Hartmann, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Rohmann, Jessica L |e verfasserin |4 aut | |
| 700 | 1 | |a Endres, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Audebert, Heinrich J |e verfasserin |4 aut | |
| 700 | 0 | |a Berlin_PRehospital Or Usual Delivery in stroke care (B_PROUD) study group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 325(2021), 5 vom: 02. Feb., Seite 454-466 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
| 773 | 1 | 8 | |g volume:325 |g year:2021 |g number:5 |g day:02 |g month:02 |g pages:454-466 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2020.26345 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 325 |j 2021 |e 5 |b 02 |c 02 |h 454-466 | ||